)
PharmX Technologies (PHX) investor relations material
PharmX Technologies H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
FY 2025 saw a 13% increase in total revenue to AUD 7.53 million, with strong growth in both gateway and marketplace segments, and a positive EBITDA of AUD 1.61 million despite increased investment in people and technology.
Marketplace revenues nearly tripled year-over-year, and gross margin improved to 82%.
Gross transaction volumes rose 18% year-over-year, and volumes-based ARR increased 20%, reflecting robust platform activity and strategic execution.
The business expanded its supplier network by 16%, completed integrations with key partners, and secured 99% coverage of the New Zealand market.
Operational improvements included early termination of revenue share agreements, team restructuring, and the launch of new supplier and pharmacy portals, analytics, and e-commerce platforms.
Financial highlights
Revenue reached AUD 7.53 million, up 13% year-over-year, with gateway revenues up 11% and marketplace revenues up 193%.
Operating costs increased to AUD 5.9 million, mainly due to investments in development, sales, marketing, and IT.
EBITDA was AUD 1.61 million, down from AUD 1.8 million, reflecting higher investment; net loss after tax was AUD 264,000, a significant improvement from a AUD 1.8 million loss in the prior year.
Receipts from customers rose 14% to AUD 8.09 million, and underlying operating cash flow was positive at AUD 902,000.
Statutory operating cash flow showed an outflow of AUD 8.1 million, mainly due to a one-off legal settlement payment; year-end cash balance was AUD 4.2 million.
Outlook and guidance
FY 2026 strategy focuses on finalizing a single platform, deepening partner relationships, expanding supplier numbers, and leveraging AI and automation for operational excellence.
Marketplace is expected to be the main driver of revenue growth in FY 2026, with a new e-commerce platform launching in November.
Increased investment planned in digital enablement and commercial resources to drive volume and engagement.
Cost base will remain stable at current levels, with continued investment in product development and technology.
No plans to diversify outside pharmacy; international expansion may be considered after achieving local targets.
Next PharmX Technologies earnings date
Next PharmX Technologies earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)